Total Payments
$251,468
2024 Payments
$47,811
Companies
67
Transactions
1,554
Medicare Patients
4,734
Medicare Billing
$890,656
Payment Breakdown by Category
Other$203,590 (81.0%)
Food & Beverage$26,630 (10.6%)
Travel$12,302 (4.9%)
Consulting$8,928 (3.6%)
Education$18.76 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $203,590 | 106 | 81.0% |
| Food and Beverage | $26,630 | 1,368 | 10.6% |
| Travel and Lodging | $12,302 | 75 | 4.9% |
| Consulting Fee | $8,928 | 3 | 3.6% |
| Education | $18.76 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $136,752 | 323 | $0 (2024) |
| Allergan, Inc. | $53,591 | 125 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $37,716 | 59 | $0 (2024) |
| ARGENX US, INC. | $4,604 | 34 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,492 | 76 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,249 | 67 | $0 (2024) |
| EMD Serono, Inc. | $1,148 | 63 | $0 (2024) |
| UCB, Inc. | $997.92 | 56 | $0 (2024) |
| GENZYME CORPORATION | $983.24 | 42 | $0 (2023) |
| Biogen, Inc. | $955.73 | 59 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47,811 | 255 | Takeda Pharmaceuticals U.S.A., Inc. ($37,698) |
| 2023 | $19,829 | 217 | AbbVie Inc. ($16,340) |
| 2022 | $67,104 | 276 | ABBVIE INC. ($60,535) |
| 2021 | $63,276 | 230 | AbbVie Inc. ($53,042) |
| 2020 | $46,365 | 169 | Allergan, Inc. ($44,771) |
| 2019 | $2,842 | 157 | GENZYME CORPORATION ($345.55) |
| 2018 | $2,228 | 135 | Allergan Inc. ($217.61) |
| 2017 | $2,013 | 115 | UCB, Inc. ($278.92) |
All Payment Transactions
1,554 individual payment records from CMS Open Payments — Page 1 of 63
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,197.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $912.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Immunology and Neurology | ||||||
| 12/16/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Analgesic | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,467.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,642.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: EPILEPSY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Travel and Lodging | In-kind items and services | $24.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Travel and Lodging | In-kind items and services | $24.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Travel and Lodging | In-kind items and services | $14.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Travel and Lodging | In-kind items and services | $12.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Travel and Lodging | In-kind items and services | $11.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $3.23 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Central Nervous System | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Travel and Lodging | In-kind items and services | $40.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Travel and Lodging | In-kind items and services | $32.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Travel and Lodging | In-kind items and services | $24.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Travel and Lodging | In-kind items and services | $24.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Neuropsychiatry | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Travel and Lodging | In-kind items and services | $12.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: AMANTADINE | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: PAIN | ||||||
| 12/03/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: Musculoskeletal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,423 | 17,872 | $841,020 | $264,352 |
| 2022 | 13 | 1,307 | 16,835 | $737,482 | $251,822 |
| 2021 | 18 | 1,170 | 16,639 | $678,919 | $226,381 |
| 2020 | 17 | 834 | 15,257 | $406,217 | $148,101 |
Total Patients
4,734
Total Services
66,603
Medicare Billing
$890,656
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 23 | 16,000 | $160,000 | $79,504 | 49.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 598 | 918 | $183,600 | $76,724 | 41.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 144 | 144 | $57,600 | $20,260 | 35.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 105 | 125 | $35,000 | $14,502 | 41.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 120 | 164 | $46,530 | $11,527 | 24.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 80 | 81 | $51,840 | $10,924 | 21.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 59 | 59 | $82,600 | $8,800 | 10.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 80 | 80 | $25,600 | $7,887 | 30.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 27 | 28 | $21,000 | $7,202 | 34.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 20 | 59 | $41,300 | $6,775 | 16.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 81 | $11,340 | $4,804 | 42.4% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 24 | 24 | $47,040 | $4,627 | 9.8% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 13 | 36 | $18,360 | $3,952 | 21.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 29 | 29 | $32,480 | $3,710 | 11.4% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 11 | 11 | $18,480 | $1,739 | 9.4% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 13 | 33 | $8,250 | $1,416 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 562 | 924 | $184,800 | $79,943 | 43.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 22 | 15,100 | $151,000 | $72,775 | 48.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 149 | 149 | $59,600 | $22,789 | 38.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 152 | 183 | $51,240 | $21,497 | 42.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 74 | 75 | $48,000 | $10,313 | 21.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 103 | 121 | $34,122 | $9,013 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $17,280 | $6,267 | 36.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 43 | 43 | $48,160 | $5,528 | 11.5% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 17 | 52 | $36,400 | $5,474 | 15.0% |
About Dr. Alexis Shaefer, M.D
Dr. Alexis Shaefer, M.D is a Neurology healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2011. The National Provider Identifier (NPI) number assigned to this provider is 1942590872.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexis Shaefer, M.D has received a total of $251,468 in payments from pharmaceutical and medical device companies, with $47,811 received in 2024. These payments were reported across 1,554 transactions from 67 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($203,590).
As a Medicare-enrolled provider, Shaefer has provided services to 4,734 Medicare beneficiaries, totaling 66,603 services with total Medicare billing of $890,656. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Augusta, GA
- Active Since 04/12/2011
- Last Updated 07/22/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1942590872
Products in Payments
- UBRELVY (Drug) $154,428
- HYQVIA (Biological) $31,723
- BOTOX (Biological) $19,946
- QULIPTA (Drug) $14,219
- AUBAGIO (Drug) $872.98
- AJOVY (Biological) $820.49
- NURTEC ODT (Drug) $775.30
- Aimovig (Biological) $767.83
- KESIMPTA (Drug) $753.94
- Fycompa (Drug) $737.45
- Briviact (Drug) $662.12
- INGREZZA (Drug) $513.70
- VYVGART HYTRULO (Drug) $505.51
- RYTARY (Drug) $471.72
- GOCOVRI (Drug) $445.08
- OCREVUS (Biological) $432.92
- TROKENDI XR (Drug) $430.31
- VALTOCO (Drug) $391.09
- GILENYA (Drug) $356.38
- VUMERITY (Drug) $346.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Augusta
John Morgan, Md, MD
Neurology — Payments: $745,663
Neurology $745,663
Dr. John Henson, Md, MD
Neurology — Payments: $71,522
Neurology $71,522
Anthony Murro, Md, MD
Neurology — Payments: $66,836
Neurology $66,836
Dr. Colin Mcleod, M.d, M.D
Neurology — Payments: $44,607
Neurology $44,607
Dr. Bryan Ho, M.d, M.D
Neurology — Payments: $29,785
Neurology $29,785
Dr. Julie Kurek
Neurology — Payments: $27,870
Neurology $27,870